Effects of Ultrasound-guide Hypertonic Dextrose Injection for Chronic Subacromial Bursitis
NCT ID: NCT04916353
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-06-10
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of Ultrasonographic Findings With Clinical Parameters in Patients With Lateral Epicondylitis
NCT07127302
Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features.
NCT00415337
Ultrasound Elastography of Breast Lesions
NCT00716482
Ultrasonic Measurement of the Area of the Anterior Superior Labrum of the Hip Joint for Diagnosis of Labrum Tear
NCT04953598
Effects of Point-of-Care Ultrasound in Multidisciplinary Medical Wards
NCT06529315
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20% hypertonic dextrose water injection group
echo guide 20% dextrose water 3ml was injection in lesion site
hypertonic dextrose water
20% hypertonic dextrose water injection for chronic shoulder pain
Steroid injection group
Triamcinolone Acetonide 40mg/ml, 1ml, and Lidocaine 2ml as the active comparator group
Triamcinolone Acetonide.
Triamcinolone Acetonide 40mg/1ml injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hypertonic dextrose water
20% hypertonic dextrose water injection for chronic shoulder pain
Triamcinolone Acetonide.
Triamcinolone Acetonide 40mg/1ml injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University Shuang Ho Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ShihWei Huang
Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lien-Chieh Lin
Role: STUDY_CHAIR
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shuang Ho Hospital
New Taipei City, Zhonghe Dist, Taiwan
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
New Taipei City, Zhonghe Dist, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N201812061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.